Answers are grounded in this paper and cite their sources.
Reversible and selective binding of a dynamically racemic europium(III) complex to α(1)-acid glycoprotein and α(1)-antitrypsin is characterised by a significant change in the europium total emission spectral fingerprint and the switching on of a large circularly polarised luminescence (CPL) signal from the metal centre. Observation of an induced CD into the ligand chromophore in the presence of α(1)-AGP allows a structure for the protein-bound complex to be postulated. A direct determination of elevated α(1)-AGP levels in human serum was achieved by monitoring changes in the intensity ratio of Eu emission bands.
No takes yet. Share an insight, caveat, or question.
Carr et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: